Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2BENLYSTA

02 1CABLIVI

03 1CINQAIR

04 1EPOPROSTENOL SODIUM

05 1FOLLISTIM AQ

06 1GONAL-F RFF REDI-JECT

07 1METHERGINE

08 1MYALEPT

09 1NUCALA

10 1RAXIBACUMAB

11 1SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE

12 1SYLVANT

13 1VELETRI

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

CAPLACIZUMAB-YHDP

Drug : CABLIVI

Dosage Form : INJECTABLE; INJECTION

Application Number : 761112

Country : US

Patented : No

Sanofi Company Banner

02

arrow
RDD 2025
Not Confirmed

03

arrow
RDD 2025
Not Confirmed

04

arrow
RDD 2025
Not Confirmed

05

arrow
RDD 2025
Not Confirmed

06

arrow
RDD 2025
Not Confirmed

07

arrow
RDD 2025
Not Confirmed
arrow
RDD 2025
Not Confirmed

FERRIC OXYHYDROXIDE

Drug : SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE

Dosage Form : INJECTABLE; INJECTION

Application Number : 78215

Country : US

Patented : No

blank

08

arrow
RDD 2025
Not Confirmed